The Cyclospora outbreak's latest evidentiary tension: On July 19, the FDA stated that a previously reported Cyclospora result π΄π©π°πΆππ₯ π£π¦ π€π°π―π΄πͺπ₯π¦π³π¦π₯ π’ π§π’ππ΄π¦ π±π°π΄πͺπ΅πͺπ·π¦. This prompts an understandable corporation relief and a renewed skepticism about statements from regulatory agencies. Note: the FDA is still telling consumers, restaurants, and retailers not to touch the recalled lettuce. … Continue reading Public Health Evidence: Strong Enough to Act, Not Clean Enough to Reassure
fda
Manufacturing is now a Biopharma Strategy
Making a great product once is a magic trick. The product becomes real only when you can make it reliably, over and over again. For the longest time, manufacturing in biopharma was treated like the person in the group project who actually did the work but never made it to the title slide. Discovery got … Continue reading Manufacturing is now a Biopharma Strategy
